Alpha Tau to Participate in October Investor Conferences
Globe Newswire•05/10/2026•09:45 ET
0
Key Highlights
- ➤Alpha Tau (DRTS) management schedules two October 2026 investor conference appearances
- ➤Barclays Biotech 1x1 Day meetings set for October 6 in New York
- ➤Investment Generation Conference presentation scheduled for October 15 in Israel
JERUSALEM, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT(®), today announced that company management will participate in the following investor conferences in October 2026.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
Get started
Create a free account to read the full story.